152 related articles for article (PubMed ID: 20887791)
1. Marine gastropod hemocyanins as adjuvants of non-conjugated bacterial and viral proteins.
Gesheva V; Idakieva K; Kerekov N; Nikolova K; Mihaylova N; Doumanova L; Tchorbanov A
Fish Shellfish Immunol; 2011 Jan; 30(1):135-42. PubMed ID: 20887791
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the immune response using Rapana thomasiana hemocyanin.
Tchorbanov A; Idakieva K; Mihaylova N; Doumanova L
Int Immunopharmacol; 2008 Jul; 8(7):1033-8. PubMed ID: 18486915
[TBL] [Abstract][Full Text] [Related]
3. Helix pomatia hemocyanin - a novel bio-adjuvant for viral and bacterial antigens.
Gesheva V; Chausheva S; Stefanova N; Mihaylova N; Doumanova L; Idakieva K; Tchorbanov A
Int Immunopharmacol; 2015 May; 26(1):162-8. PubMed ID: 25799956
[TBL] [Abstract][Full Text] [Related]
4. Enhanced structural stability of Concholepas hemocyanin increases its immunogenicity and maintains its non-specific immunostimulatory effects.
Arancibia S; Del Campo M; Nova E; Salazar F; Becker MI
Eur J Immunol; 2012 Mar; 42(3):688-99. PubMed ID: 22144228
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant properties of bacterial product cantastim.
Anghelache IF; Caras I; Salageanu A
Roum Arch Microbiol Immunol; 2007; 66(1-2):17-21. PubMed ID: 18928058
[TBL] [Abstract][Full Text] [Related]
6. Intranasal immunization with tetanus toxoid and CNF1 as a new mucosal adjuvant protects BALB/c mice against lethal challenge.
Munro P; Flatau G; Lemichez E
Vaccine; 2007 Dec; 25(52):8702-6. PubMed ID: 18035455
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of glycosylated molluscan hemocyanins via Guerin ascites tumor.
Dolashka P; Velkova L; Iliev I; Beck A; Dolashki A; Yossifova L; Toshkova R; Voelter W; Zacharieva S
Immunol Invest; 2011; 40(2):130-49. PubMed ID: 20923331
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of tetanus toxoid-specific immune responses by a traditional Chinese herbal medicine.
Underwood JR; Chivers M; Dang TT; Licciardi PV
Vaccine; 2009 Nov; 27(47):6634-41. PubMed ID: 19781825
[TBL] [Abstract][Full Text] [Related]
9. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
10. The context of tetanus toxoid application influences the outcome of antigen-specific and self-directed humoral immune response.
Stojanović M; Zivković I; Inić-Kanada A; Petrusić V; Mićić M; Dimitrijević L
Microbiol Immunol; 2009 Feb; 53(2):89-100. PubMed ID: 19291092
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapeutic effect of Concholepas hemocyanin in the murine bladder cancer model: evidence for conserved antitumor properties among hemocyanins.
Moltedo B; Faunes F; Haussmann D; De Ioannes P; De Ioannes AE; Puente J; Becker MI
J Urol; 2006 Dec; 176(6 Pt 1):2690-5. PubMed ID: 17085197
[TBL] [Abstract][Full Text] [Related]
12. An inter-laboratory retrospective analysis of immunotoxicological endpoints in non-human primates: T-cell-dependent antibody responses.
Lebrec H; Cowan L; Lagrou M; Krejsa C; Neradilek MB; Polissar NL; Black L; Bussiere J
J Immunotoxicol; 2011; 8(3):238-50. PubMed ID: 21692639
[TBL] [Abstract][Full Text] [Related]
13. Immunization with a DNA chimeric molecule encoding a hemagglutinin peptide and a scFv CD21-specific antibody fragment induces long-lasting IgM and CTL responses to influenza virus.
Ivanovska N; Tchorbanov A; Prechl J; Maximova V; Voynova E; Vassilev TL
Vaccine; 2006 Mar; 24(11):1830-7. PubMed ID: 16289708
[TBL] [Abstract][Full Text] [Related]
14. Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice.
Quintilio W; Kubrusly FS; Iourtov D; Miyaki C; Sakauchi MA; Lúcio F; Dias Sde C; Takata CS; Miyaji EN; Higashi HG; Leite LC; Raw I
Vaccine; 2009 Jun; 27(31):4219-24. PubMed ID: 19393709
[TBL] [Abstract][Full Text] [Related]
15. Immunological potential of Helix vulgaris and Rapana venosa hemocyanins.
Dolashka-Angelova P; Stefanova T; Livaniou E; Velkova L; Klimentzou P; Stevanovic S; Salvato B; Neychev H; Voelter W
Immunol Invest; 2008; 37(8):822-40. PubMed ID: 18991098
[TBL] [Abstract][Full Text] [Related]
16. Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.
Radosević K; Rodriguez A; Mintardjo R; Tax D; Bengtsson KL; Thompson C; Zambon M; Weverling GJ; Uytdehaag F; Goudsmit J
Vaccine; 2008 Jul; 26(29-30):3640-6. PubMed ID: 18514980
[TBL] [Abstract][Full Text] [Related]
17. GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21.
Helling F; Zhang S; Shang A; Adluri S; Calves M; Koganty R; Longenecker BM; Yao TJ; Oettgen HF; Livingston PO
Cancer Res; 1995 Jul; 55(13):2783-8. PubMed ID: 7796403
[TBL] [Abstract][Full Text] [Related]
18. Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine.
Asanuma H; Fujihashi K; Miyakoshi T; Yoshikawa T; Fujita-Yamaguchi Y; Kojima N; Nakata M; Suzuki Y; Tamura S; Kurata T; Sata T
Vaccine; 2007 Sep; 25(39-40):6975-80. PubMed ID: 17716790
[TBL] [Abstract][Full Text] [Related]
19. Cross-clade protection against HPAI H5N1 influenza virus challenge in BALB/c mice intranasally administered adjuvant-combined influenza vaccine.
Yang P; Tang C; Luo D; Zhan Z; Xing L; Duan Y; Jia W; Peng D; Liu X; Wang X
Vet Microbiol; 2010 Nov; 146(1-2):17-23. PubMed ID: 20888151
[TBL] [Abstract][Full Text] [Related]
20. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
Bungener L; Geeraedts F; Ter Veer W; Medema J; Wilschut J; Huckriede A
Vaccine; 2008 May; 26(19):2350-9. PubMed ID: 18400340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
